From bench to podium: how CEPID CancerThera skin cancer innovation has achieved the Unicamp 2026 Challenge
When frontier science meets the market vision, the result is the acceleration of the future. It is with this spirit
Science that transforms: 3rd Julho Verde Symposium and 1st Reconneckt Symposium join forces for oncological advancement
Oncological medicine is going through a moment of transformation in which technical excellence needs to go hand in hand with
Principal investigator at CEPID CancerThera, Elba Etchebehere joins the new editorial board of the scientific journal Seminars in Nuclear Medicine
Dr. Elba Etchebehere, a nuclear medicine physician, professor at the Faculty of Medical Sciences of the State University of Campinas
Scientific diffusion and literacy: workshop on radiopharmaceuticals brings researchers and the press together
The fight against misinformation and the strengthening of scientific journalism inevitably involves the approximation between those who produce science and
From scientific rigor to clinical impact: the pathways of innovation at the 2nd CancerThera Seminar
What separates a promising laboratory discovery from an effective solution for cancer patients? This was the central theme of the
Researchers from CEPID CancerThera Participate in the SNMMI Annual Meeting in the United States; Presented Study Receives Best International Abstract Award
From May 30 to June 2, Los Angeles (United States) hosted the SNMMI Annual Meeting (Society of Nuclear Medicine &
CancerThera Principal Investigator Carmino Antonio de Souza Elected Full Member of the São Paulo Academy of Medicine
At an Extraordinary General Assembly held on June 10, onco-hematologist Dr. Carmino Antonio de Souza was elected a Full Member
CEPID CancerThera brings Campinas public school students closer to cancer research at Viva Ciência 2026
Between May 19 and 21, the Exploratory Science Museum of the State University of Campinas (MEC/Unicamp) became a vibrant hub
Principal investigator at CEPID CancerThera, Elba Etchebehere joins the advisory board of a new journal from The Lancet group
Dr. Elba Etchebehere, nuclear medicine physician and principal investigator at CEPID CancerThera, has just been appointed as a member of
Study by CEPID CancerThera reveals that social vulnerability interferes with the prognosis of cancer patients in Campinas
Campinas has a Human Development Index (HDI) considered very high (0.805) and an urbanization rate of 98.28%, figures often comparable